Relapsed/Refractory Lymphomas
1 clinical trials · Condition
◉ Watch Relapsed/Refractory Lymphomas
| Record | Firm | Date |
|---|---|---|
| A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer (NCT06678659) | Recursion Pharmaceuticals Inc. | 2024-11-21 |
Track Relapsed/Refractory Lymphomas automatically
Every clearance here is in the API, with alerts when new ones post.